As of Aug 15
| 0.00 / 0.00%|
Panacos Pharmaceuticals, Inc. is a development stage company. The company is engaged in the discovery and development of small-molecule oral drug which is designed to treat human immunodeficiency virus and other major human viral diseases. Its primary product is Bevirimat, which is an oral human immunodeficiency virus which provides a novel mechanism of action called maturation inhibition. The company was founded by Graham Allaway in March 2005 and is headquartered in Watertown, MA.
|John R. Barr||President & Chief Executive Officer|
|Thomas T. Higgins||Chief Financial Officer|